Abstract
Polymorphisms in genes that encode P450 cytochrome enzymes may increase carcinogen activation or decrease their inactivation and consequently, promote the development of cancer. The aims of this study were to identify the MspI-CYP1A1, PstI-CYP2E1 and DraI-CYP2E1 polymorphisms in patients with head and neck cancer and to compare with individuals without cancer; to evaluate the association of these polymorphisms with risk factors and clinical histopathological parameters. In the study group, 313 patients were evaluated for CYP1A1, 217 for CYP2E1 (PstI) and 211 for CYP2E1 (DraI) and in the control group 417, 334 and 374 individuals, respectively. Molecular analysis was performed by PCR–RFLP technique, and chi-square and multiple logistic regression tests were used for statistical analysis. The result of analysis regarding individuals evaluated for CYP1A1 (MspI) showed that age (OR: 8.15; 95% CI 5.57–11.92) and smoking (OR: 5.37; 95% CI 3.52–8.21) were predictors for the disease; for the CYP2E1 (PstI and DraI), there were associations with age (PstI-OR: 9.10; 95% CI 5.86–14.14/DraI-OR: 8.07; 95% CI 5.12–12.72), smoking (PstI-OR: 4.10; 95% CI 2.44–6.89/DraI-OR: 5.73; 95% CI 3.34–9.82), alcohol (PstI-OR: 1.93; 95% CI 1.18–3.16/DraI-OR: 1.69; 95% CI 1.02–2.81), respectively, with disease development. CYP2E1 (PstI) was less frequent in patient group (OR: 0.48; 95% CI 0.23–0.98). Regarding clinical histopathological parameters, CYP1A1 polymorphism was less frequent in the larynx primary anatomic site (OR = 0.45; 95% CI = 0.28–0.73; P = 0.014). In conclusion, we confirm that age, smoking and alcohol consumption are risk factors for this disease and the polymorphisms investigated have no association with the development of head and neck cancer.
Similar content being viewed by others
References
Ragin CC, Modugno F, Gollin SM (2007) The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 86:104
Olivieri EHR, da Silva SD, Mendonça FF, Urata YN, Vidal DO, Faria MAM et al (2009) CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients. Oral Oncol 45(9):73–79
Curado MP, Hashibe M (2009) Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21:194–200
Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP et al (2008) Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of HNSCC: pooled analysis in the international HNSCC epidemiology consortium. J Natl Cancer Inst 99(10):777–789, 2007. Erratum in: J Natl Cancer Inst 100(3):225
Hiyama T, Yoshihara M, Tamaka S, Chayama K (2008) Genetic polymorphisms and head and neck cancer risk. Int J Oncol 32:945–973
Zain RB (2007) Cultural and dietary risk factors of oral cancer and precancer—a brief overview. Oral Oncol 37:205–210
Guengerich FP (2007) Mechanisms of cytochrome P450 substrate oxidation: minireview. J Biochem Mol Toxicol 21(4):163–168
Abbas A, Delvinquiére K, Lechevrel M, Lebailly P, Gauduchon P, Launoy G et al (2004) GSTM1, GSTT, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility esophageal cancer in French population: Different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol 23:3389–3393
Evans AJ, Henner WD, Eilers KM, Montalto MA, Wersinger EM, Andersen PE et al (2004) Polymorphisms of GSTT1 and related genes in head and neck cancer risk. Head Neck 26:63–70
Liu S, Park JY, Schantz SP, Stern JC, Lazarus P (2001) Elucidation of CYP2E1 5′ regulatory RsaI/PstI allelic variants and their role in risk of oral cancer. Oral Oncol 37:437–445
Harth V, Schäfer M, Abel J, Maintz L, Neuhaus T, Besuden M et al (2008) Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair 2. J Toxicol Environ Health 71:887–897
Wunsch A, Ahda Y, Banaz-YaSar F, Sonntag B, Nieschlag E, Simoni M et al (2005) Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor. Fertil Steril 84(2):446–453
Androtsopoulos VP, Tsatsakis AM, Spandidos DA (2009) Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. BMC Cancer 9:187
Rusin P, Marckiewicz L, Majsterek I (2008) Genetic predeterminations of head and neck cancer. Postepy Hig Med Dosw 62:490–501
Božina N, Bradamante V, Lovrić M (2009) Genetic polymorphism of metabolic enzymes P450 (Cyp) as a susceptibility factor for drug response, toxicity, and cancer risk. Arh Hig Rada Toksikol 60:217–242
Gattas GJF, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, Eluf-Neto J et al (2006) Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck 28:819–826
Liu R, Yin LH, Pu YP (2007) Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai’an population, China. Chin Med J 120:1797–1802
Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC, Ankathil R (2005) Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet 50:618–627
Juárez-Cedillo T, Vallejo M, Fragoso JM, Hernández-Hernández DM, Rodríguez-Pérez JM, Sánchez-García S et al (2007) The risk of developing cervical cancer in Mexican women is associated to CYP1A1 MspI polymorphism. Eur J Cancer 43(10):1590–1595
Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K (2005) CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 574:112–123
Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK et al (1997) CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer 89:1207–1212
Lee KJ (2003) Essential otorhinolaryngology. Head Neck Surg 8:1136
Liu CJ, Chang CS, Lui MT, Dang CW, Shih YH, Chang KW (2005) Association of GST genotypes whith age of onset and lymph node metatasis in oral squamous cell carcinoma. J Oral Pathol Med 54:475–481
Instituto Nacional do Câncer. UICC—União Internacional Contra o Câncer, 2002—TNM—Classificação de Tumores Malignos 6ª. Edição. Ministério da Saúde. Rio de Janeiro: INCA 2004
Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (2002) AJCC Cancer Staging Manual, 6th ed. New York, Springer
Sobin LH, Wittelind CH (2000) Internacional union against cancer: TNM classification of malignant tumours, 6th edn. Wiley, New York
Ahrendt SA, Chown JT, Yang SC, Wu L, Zhang M-J, Jen J et al (2000) Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in nomsmall cell lung cancer. Cancer Res 60:3155–3159
Kjaerheim K, Gaard M, Andersen A (1998) The role of alcohol, tobacco, and dietary factors in upper aerogastric tract cancers: a prospective study of 10,900 Norwegian men. Cancer Causes Control 9(1):99–108
Miller AS, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Arvanitis DA, Goumenou AG, Matalliotaski IM, Koumantaski EE, Spandidos DA (2001) Low penetrance genes are associated with increased susceptibility to endometriosis. Fertil Steril 76:1202
Kato S, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H et al (1992) Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 52:6712–6715
Hirvonen A, Husgafvel-Pursianen K, Karjalainen A, Antilla S, Vainio H (1993) The human CYP2E1 gene and lung cancer: Dra1 and Rsa1 restriction length polymorphisms in a Finnish study population. Carcinogenesis 14:85–88
Goldstein DP, Irish JC (2005) Head and neck squamous cell carcinoma in the young patient. Curr Opin Otolar & Head Neck Surg 13:207–211
Marques CFS, Koifman S, Koifman RJ, Boffetta P, Brennan P, Hatagima A (2006) Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro. Oral Oncol 42:632–637
Galbiatti AL, Ruiz MT, Rezende Pinto D, Raposo LS, Maníglia JV, Pavarino-Bertelli EC et al. (2010) A80G polymorphism of reduced folate carrier 1 (RFC1) gene and head and neck squamous cell carcinoma etiology in Brazilian population. Mol Biol Rep. dio:10.1007/s11033-010-0204-1
Boffeta P, Hashibe M (2006) Alcohol and cancer. Lancet Oncol 7:149–156
Warnakulasuriya S, Sutherland G, Scully C (2008) Tobacco, oral cancer, and treatment of dependence. Oral Oncol 41:244–260
Dedivitis RA, França CM, Mafra ACB, Guimarães FT, Guimarães AV (2004) Características clínicoepidemiológicas no carcinoma espinocelular de boca e orofaringe. Ver Bras Otorhinolaryngol 70:35–40
Lung T, Tascau OC, Almasan HA, Muresan O (2007) Head and neck cancer, epidemiology and histological aspects Part 1: A decade′s result 1993–2002. J Craniomaxillofac Surg 35:120–125
Hershkovich O, Shafat I, Nagler RM (2007) Age-related changes in salivary antioxidant profile: possible implications for oral cancer. J Gerontol A Biol Sci Med Sci 62:361–366
Du D, Shi YH, Le GW (2010) Oxidative stress induced by high-glucose diet in liver of C57BL/6 J mice and its underlying mechanism. Mol Biol Rep 37:3833–3839
Gronau S, Koing-Greger D, jerg M, Riechelmann H (2003) Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer? Otorhinolaryngol Head Neck Surg 5:674–680
Buch SC, Nazar-Stewart V, Weissfeld JL, Romkers M (2008) Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes. Head Neck 30:1139–1147
Singh AP, Shah PP, Ruwali M, Mathur N, Pant MC, Parmar D (2009) Related articles polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk. Cancer Invest 27(8):869–876
Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J (1999) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett 263:131–133
Houlston RS (2000) CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. Pharmacogenetics 10(2):105–114
Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, Butkiewicz D et al (2003) Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol 32:60–63
Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML et al (2003) CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 104:650–657
Goodman MT, McDuffie K, Hernandez B et al (2001) CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol 81:263–269
Cha I-H, Park JY, Chung W-Y, Choi M-A, Kim H-J, Park K-k (2007) Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsci Med J 48:233–239
Leichsenring A, Losi-Guembarovski R, Maciel ME, Losi-Guembarovski A, Oliveira BW, Ramos G et al (2006) CYP1A1 and GSTP1 polymorphisms in an oral cancer case-control study. Braz J Med Biol Res 39(12):1569–1574
Bergheim I, Wolfgarten E, Bollschweiler E, Hölscher AH, Bode C, Parlesak A (2007) Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma. World J Gastroenterol 13(7):997–1002
Matthias C, Jahnke V, Jones PW, Hoban PR, Alldersea JE, Worrall SF et al (1999) Cyclin D1, glutathione S-transferase, and cytocrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: assessment of the importance of individual genes using multivariate analysis. Cancer Epidemiol Biomakers Prev 8:815–823
Katoh T, Kaneko S, Kohshi K, Munaka M, Kitagawa K, Kunugita N et al (1999) Genetic polymorphisms of tobacco and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer 83:606–609
Neuhaus T, Ko YD, Lorenzen K, Fronhoffs S, Harth V, Bröde P et al (2004) Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer. Toxicol Lett 151:273–282
Boccia S, Cadoni G, Sayed-Tabatabaei FA, Volante M, Arzani D, Lauretis A (2008) CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol 134:93–100
Hildesheim A, Chen CJ, Caporaso NE, Cheng YJ, Hoover RN, Hsu MM et al (1995) Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan. Cancer Epidemiol Biomarkers Prev 4:607–610
Kongruttanachok N, Sukdikul S, Setavarin S, Kerekhjanarong V, Supiyaphun P, Voravud N et al (2001) Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer 1:4
Gonzalez MV, Alvarez V, Pello MF, Menendez MJ, Suarez C, Coto E (1998) Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J Clin Pathol 51:294–298
Gao CM, Takezaki T, Wu JZ, Chen MB, Liu YT, Ding JH et al (2007) CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking. World J Gastroenterol 13:5725–5730
Sugimura T, Kumimoto H, Tohnai I, Fukui T, Matsuo K, Tsurusako S et al (2006) Gene-environment interaction involved in oral carcinogenesis: molecular epidemio- logical study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med 35:11–18
Bouchard C, Hirvonen A, Coutelle C, Ward PJ, Dayer P, Benhamou S (2000) Role of alcohol dehydrogenase 3 and cytochrome P-450E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 87:734–740
Agulnik M (2007) Malignancies of head and neck: the role for molecular targeted agents. Expert Opin Ther Targets 11(2):207–217
Stwart BM, Kleihues P (2003) World cancer report. IARC Press, Lyon
Matthias C, Bockmuhl U, Jahnke V, Jones PW, Hayes JD, Alldersea J et al (1998) Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 8:91–100
Acknowledgments
The authors are grateful to participation of the Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-CAPES and Conselho Nacional de Desenvolvimento Cientıífico e Tecnológico-CNPq for their support and FAMERP/FUNFARME in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cury, N.M., Russo, A., Galbiatti, A.L.S. et al. Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk. Mol Biol Rep 39, 1055–1063 (2012). https://doi.org/10.1007/s11033-011-0831-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-011-0831-1